AUM BioTech
AUM BioTech offers functional genomics research tools in the area of RNA silencing and regulation for basic, transitional and pre-clinical research.
Our FANA technology can target – mRNA, microRNA and lncRNA. AUM BioTech's next generation self-deliverable RNA silencing technology provides superior and cheaper alternatives to CRISPR, siRNA and shRNA approaches.
01/25/2022
AUM BioTech congratulates Beatrice Bodega, Federica Marasca, and their team on Nature Genetics paper ‘LINE1 are spliced in non-canonical transcript variants to regulate T cell quiescence and exhaustion'.
We are excited to see the robust use and multiple applications of self-delivering FANA A*O for RNA silencing and genomic regulation in this important study.
https://www.nature.com/articles/s41588-021-00989-7
11/02/2021
As a part of our educational series, today we highlight a publication in Science Immunology entitled 'Activation of mTORC1 at late endosomes misdirects T cell fate decision in older individuals', which describes a strategy to enhance T cell immunity. aumbiotech.com/Publications
Are you working with neural cell lines, primary neurons, or animal models?
Check out our self-delivering RNA silencing products for research in neuroscience.
Get a free sample today @ www.aumbiotech.com
Self-delivering RNA silencing oligos. No transfection reagents needed. Get your free sample today @ www.aumbiotech.com
10/20/2021
New peer-reviewed research in Biomarker Research uses self-delivering RNA silencing FANA A*Os, showing lncRNA TEX41 is upregulated in pediatric B-Cells Acute Lymphoblastic Leukemia and the importance of TEX41 as a novel potential biomarker for diagnosis!
Read the article by checking our latest post on aumbiotech.com/Publications
Try ‘s RNA silencing products today. Gene knockdown guarantee. Free Shipping. Link in bio.
AUM BioTech is proud to support and the scientific community with awards up to $10,000. We invite you to apply here:
https//www.aumbiotech.com
06/10/2021
Starting today our research collaborator and preclinical stage company, AUM LifeTech, is participating in 2021.
Selected by the National Institutes of Health (NIH), AUM LifeTech will be active in the largest global biotech conversations alongside industry leaders and peers to showcase new preclinical data on lung cancer, Parkinson’s Disease, and infectious diseases 🦠
Discover FANA A*O RNA silencing technology and the findings at BIO Digital’s Innovation Stage this week and next.
06/07/2021
AUM LifeTech, a preclinical stage gene therapy company and our research collaborator, has been selected by the National Institutes of Health (NIH) to participate in 2021 starting June 10. Joining the largest global biotech partnering event, AUM LifeTech will be presenting update on their therapeutic programs in lung cancer, Parkinson’s Disease, and infectious diseases using self-delivering FANA A*O RNA silencing technology 🧬
We hope to see you there!
05/28/2021
Many silently suffer with mental health—scientists and researchers are no different.
As Mental Health Awareness Month comes to an end, we are proud to have helped encourage the conversation around this critical issue by donating reusable mental health masks to our community 💚
04/25/2021
celebrates two achievements for science!
The 1953 discovery of the DNA's double helix and the 2003 completion of the Human Genome Project 🧬
And we are here to support nucleic acids research through our highly potent, self-delivering RNA silencing technology 💪
Click here to claim your Sponsored Listing.
Category
Contact the business
Website
Address
3675 Market Street, Suite 200
Philadelphia, PA
19104